Reduced activity of ACE2, which regulates angiotensin II concentrations in the regulatory RAS pathway, also lends support to the notion of a detrimental involvement of excess concentrations of angiotensin II in Alzheimer's disease.7 Here, ACE2 is linked to early-onset autosomal dominant Alzheimer disease.